Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Benefit Design topic
No spam. Unsubscribe anytime.
SEBB board reviews 2027 benefit‑design changes including HIV antiviral mandate and birth‑doula coverage
Summary
At its June 24 meeting the School Employees Benefits Board reviewed proposed 2027 benefit‑design changes across carrier plans, including a legislative mandate on HIV antivirals, new birth‑doula benefits, expanded non‑emergency transport coverage and related carrier implementation differences; the board will vote on premium resolutions July 9.
The School Employees Benefits Board on June 24 heard a package of proposed benefit‑design changes for plan year 2027 affecting SEBB members across multiple carriers. Christine Davis, procurement manager, introduced the portfolio changes and said carriers would implement a mix of mandated and discretionary changes that the board can accept only as part of whole‑plan authorizations later this summer.
Several changes reflect new state law and marketwide shifts. Director Moran described one legislative change as “a bill that applies to a variety of different parts of the market,” referencing Senate Bill 6,183, which staff said requires coverage of FDA‑approved antiviral drugs for prevention or treatment of HIV without step therapy. Carriers will differ in how they operationalize the requirement (for example, covering generics when therapeutically equivalent). Staff flagged other common additions: a birth‑doula benefit across plans (details and limits vary by carrier) and expanded non‑emergency post‑discharge medical transportation by wheelchair or gurney vans when ordered by a network provider.
